Kenneth Lombard, MD | |
887 Congress St, Suite 410b, Portland, ME 04102-3100 | |
(207) 662-5522 | |
(207) 662-5526 |
Full Name | Kenneth Lombard |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Gastroenterology |
Location | 887 Congress St, Portland, Maine |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013946011 | NPI | - | NPPES |
337220099 | Medicaid | ME | |
30006480 | Medicaid | NH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 013678 (Maine) | Secondary |
2080P0206X | Pediatrics - Pediatric Gastroenterology | 013678 (Maine) | Primary |
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134144090 PECOS PAC ID: 9335043967 Enrollment ID: O20040331000191 |
News Archive
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers.
As part of its ongoing commitment to ensuring safe, appropriate and effective medical imaging and radiation therapy, the Medical Imaging & Technology Alliance (MITA) announced today a new industry-wide commitment to more expansively address patient safety in medical imaging by including new radiation dose safeguards.
UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.
The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.
› Verified 3 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers.
As part of its ongoing commitment to ensuring safe, appropriate and effective medical imaging and radiation therapy, the Medical Imaging & Technology Alliance (MITA) announced today a new industry-wide commitment to more expansively address patient safety in medical imaging by including new radiation dose safeguards.
UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.
The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.
› Verified 3 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992719272 PECOS PAC ID: 9335043967 Enrollment ID: O20050901000035 |
News Archive
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers.
As part of its ongoing commitment to ensuring safe, appropriate and effective medical imaging and radiation therapy, the Medical Imaging & Technology Alliance (MITA) announced today a new industry-wide commitment to more expansively address patient safety in medical imaging by including new radiation dose safeguards.
UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.
The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kenneth Lombard, MD 301 Us Route 1, Building C, Scarborough, ME 04074-7609 Ph: (207) 396-8600 | Kenneth Lombard, MD 887 Congress St, Suite 410b, Portland, ME 04102-3100 Ph: (207) 662-5522 |
News Archive
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers.
As part of its ongoing commitment to ensuring safe, appropriate and effective medical imaging and radiation therapy, the Medical Imaging & Technology Alliance (MITA) announced today a new industry-wide commitment to more expansively address patient safety in medical imaging by including new radiation dose safeguards.
UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.
The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.
› Verified 3 days ago
Dr. Thomas Mellow, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 887 Congress St, Suite 320, Portland, ME 04102 Phone: 207-662-5522 Fax: 207-662-5527 | |
Rushika M Conroy, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 41 Donald B Dean Dr Ste A, Portland, ME 04106 Phone: 207-661-6064 | |
Michael Alexander Ferguson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Mmc Picu, Portland, ME 04102 Phone: 207-662-6711 | |
Dr. Rute S Rothwell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-7060 | |
David F Cox, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2353 | |
Marie H Tanzer, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 887 Congress St, Suite 320, Portland, ME 04102 Phone: 207-662-5522 Fax: 207-662-5527 |